Pairing your Semaglutide treatment with high-protein meals, daily movement, hydration, and regular provider check-ins helps maximize results
FOR IMMEDIATE RELEASE FROM MARY ANN LIEBERT, INC., PUBLISHERS New Rochelle, NY, January 8, 2025 A new study found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer
It's still the brand synonymous with a slimmer body
As more clinical studies continue to validate their benefits, the future of diabetes and weight management looks more promising than ever
After first use, store at room temperature (5986F / 1530C) or refrigerated (28C) for up to 56 days
Best Practices and Monitoring To ensure optimal outcomes, experts recommend pairing IGF-1 LR3 or any growth-factor therapy with lifestyle and medical guidance: Medical oversight: Always begin therapy after baseline hormone and glucose testing